Trustfeed Corp.
TRFE
Other OTC0.37
USD
- -
- -
CIK
0001265521
ISIN
US8983911079
Return %
Stock
S&P500
1Y
-63.31
18.21
3Y
-99.71
64.38
5Y
-99.04
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Terrence M. Tierney
- Full Time Employees
- 1
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 45801B Sandia Creek Drive Temecula CA United States of America 92590
- IPO Date
- Feb 9, 2009
- CIK
- 0001265521
- Website
- healthmedservicesltd.com
- Similar Companies
- Business
- Trustfeed Corp. Trustfeed Corp. (OTC: TRFE), formerly HealthMed Services Ltd., operates as a technology company providing software-as-a-service (SaaS) applications and services focused on trusted company information, product reviews, and ratings through its global database covering over 50 million company domains across 130 countries; core offerings include its proprietary COVA (Crawl, Aggregate, Verify, Organize) system utilizing state-of-the-art web-crawling technology, machine learning, and artificial intelligence to deliver verified company profiles, aggregated reviews, algorithmic ratings that filter suspicious content, and modular subscription models with free basic access for businesses alongside paid premium features for enhanced profiles, org charts, product details, and contact information. The company targets both business-to-business (B2B) and business-to-consumer (B2C) customers seeking reliable due diligence on companies and products, emphasizing trust in digital purchasing decisions amid prevalent fake reviews and inconsistent data sources. Founded in 2000 and headquartered at 140 Broadway, 46th Floor, New York, NY 10005, with additional facilities in Valby, Denmark, Trustfeed maintains no subsidiaries and generates revenue through its flexible subscription tiers and user-contributed reviews. In recent developments within the last two years, Polomar Specialty Pharmacy LLC completed a reverse merger acquisition of Trustfeed Corp. on June 28, 2024, leading to a strategic pivot from review platforms; the company executed a Know How and Patent License Agreement on June 29, 2024 (restated January 9, 2025) with Pinata Holdings, Inc. for worldwide non-exclusive rights to patent-pending intellectual property on inhalable and other delivery methods for metformin, eletriptan, sumatriptan, semaglutide, liraglutide, and sildenafil; effective September 30, 2024, the merger with Polomar was finalized as a reverse recapitalization, ceasing prior review business operations and shifting to compounded pharmacy fulfillment including sterile GLP-1 agonists and men's health drugs via contracts with ForHumanity Health, Inc. and CareValidate, Inc.; the trading symbol changed from TRFE to PMHS effective December 12, 2024; and on July 23, 2025, the company entered a merger agreement with Altanine Inc. positioning former Altanine stockholders to own approximately 80% of the combined entity.
Fastbase Inc. Ventures into Artificial Intelligence to Elevate Its Data-Driven Marketing Solutions
Trustfeed Corp (OTC:TRFE) Confirms effectiveness of its Form 10 filing